Sensitivity of Non-Small-Cell Lung Cancer Cell Lines Established from Patients Treated with Prolonged Infusions of Paclitaxel
作者： Takashi Fujishita , Massimo Loda , Ross E. Turner , Marinshine Gentler , Tatsuhiko Kashii
DOI: 10.1159/000070299
关键词:
摘要: Objective: Regimens with prolonged infusions of taxanes have been developed for patients cancer to overcome drug resistance. Our objective the present study was examine t
sci-hub.se 参考文章(31)
Tetsuya Mitsudomi, Chun Ming Tsai, Adi F. Gazdar, Mei Hui Chen, Reury Perng Perng, Li Hua Wu, Kuo Ting Chang, Jeou Yuan Chen, Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines. Cancer Research. ,vol. 56, pp. 206- 209 ,(1996)
F Nathan, C Khater, N Haas, M Cornfield, B Giantonio, R Greenberg, L Gomella, S Litwin, E Ross, S Roethke, C McAleer, G R Hudes, Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer. Journal of Clinical Oncology. ,vol. 15, pp. 3156- 3163 ,(1997) , 10.1200/JCO.1997.15.9.3156
Edward K. Russell, Bruce E. Johnson, Adi F. Gazdar, Mark S. Georgiadis, Paclitaxel cytotoxicity against human lung cancer cell lines increases with prolonged exposure durations. Clinical Cancer Research. ,vol. 3, pp. 449- 454 ,(1997)
M S Georgiadis, B S Schuler, J E Brown, L V Kieffer, S M Steinberg, W H Wilson, C H Takimoto, M J Kelley, B E Johnson, Paclitaxel by 96-hour continuous infusion in combination with cisplatin : A phase I trial in patients with advanced lung cancer Journal of Clinical Oncology. ,vol. 15, pp. 735- 743 ,(1997) , 10.1200/JCO.1997.15.2.735
Françoise Guéritte-Voegelein, François Lavelle, Daniel Guénard, Marie-Christine Bissery, Experimental Antitumor Activity of Taxotere (RP 56976, NSC 628503), a Taxol Analogue Cancer Research. ,vol. 51, pp. 4845- 4852 ,(1991)
W H Wilson, B A Chabner, G Bryant, S Bates, A Fojo, J Regis, E S Jaffe, S M Steinberg, B R Goldspiel, B D Cheson, Phase II study of paclitaxel in relapsed non-Hodgkin's lymphomas. Journal of Clinical Oncology. ,vol. 13, pp. 381- 386 ,(1995) , 10.1200/JCO.1995.13.2.381
Karen Kelly, John Crowley, Paul A. Bunn, Cary A. Presant, Patra K. Grevstad, Carol M. Moinpour, Scott D. Ramsey, Antoinette J. Wozniak, Geoffrey R. Weiss, Dennis F. Moore, Valerie K. Israel, Robert B. Livingston, David R. Gandara, Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial Journal of Clinical Oncology. ,vol. 19, pp. 3210- 3218 ,(2001) , 10.1200/JCO.2001.19.13.3210
Yoshiyuki Abe, Masato Nakamura, Eiichiro Ota, Yuichi Ozeki, Seiichi Tamai, Hiroshi Inoue, Yoshito Ueyama, Toshiro Ogata, Norikazu Tamaoki, Expression of the Multidrug Resistance Gene (MDR1) in Non-small Cell Lung Cancer Japanese Journal of Cancer Research. ,vol. 85, pp. 536- 541 ,(1994) , 10.1111/J.1349-7006.1994.TB02392.X
Herbert K. Oie, Edward K. Russell, Desmond N. Carney, Adi F. Gazdar, Cell culture methods for the establishment of the NCI series of lung cancer cell lines Journal of Cellular Biochemistry. ,vol. 63, pp. 24- 31 ,(1996) , 10.1002/JCB.240630504
Y KIYOZUKA, H NISHIMURA, A NAKASHIMA, K IMAMURA, S OTA, M YAKUSHIJI, S IMAI, M MORIMATSU, IN-VITRO CYTOTOXICITY IN OVARIAN-CANCER OF LOW-DOSE CONTINUOUS EXPOSURE TO MICROTUBULE INHIBITORS (PACLITAXEL TAXOTERE) COMBINED WITH CISPLATIN Oncology Reports. ,vol. 2, pp. 517- 523 ,(1995) , 10.3892/OR.2.4.517